Published in Br Heart J on April 01, 1984
Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. J Clin Invest (1996) 2.09
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart (2000) 1.66
Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J (1990) 1.49
The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.32
Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest (1992) 1.30
Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. Br Heart J (1993) 1.15
A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart (1999) 1.14
Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy. Biophys J (1998) 1.04
Sudden death from cardiovascular disease in young athletes: fact or fiction? Br J Sports Med (1997) 1.03
The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J (1994) 0.93
Role of calcium in the induction of cardiac hypertrophy and myofibrillar disarray. Experimental studies of a possible cause of hypertrophic cardiomyopathy. Br Heart J (1985) 0.90
Multiple disease genes cause hypertrophic cardiomyopathy. Br Heart J (1994) 0.84
Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J (2009) 0.83
Electrophysiological investigation of patients with hypertrophic cardiomyopathy. Evidence that slowed intraventricular conduction is associated with an increased risk of sudden death. Br Heart J (1994) 0.78
Hypertrophic Cardiomyopathy. Curr Treat Options Cardiovasc Med (2002) 0.77
Genetic investigation and counselling of families with hypertrophic cardiomyopathy. Br Heart J (1994) 0.76
Electrophysiological disturbances in heart failure. Br Heart J (1994) 0.75
Sudden cardiac death in patients with nonischemic cardiomyopathy. Indian Heart J (2014) 0.75
Problems in diagnosis and management of hypertrophic cardiomyopathy. Postgrad Med J (1991) 0.75
Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy. Curr Cardiol Rep (2017) 0.75
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation (1979) 2.68
Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation (1972) 2.49
Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation (1981) 1.66
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy. Circulation (1979) 1.41
Asymmetric septal hypertrophy and myocardial fiber disarray. Features of normal, developing, and malformed hearts. Circulation (1977) 1.37
Myocardial disarray. A critical review. Br Heart J (1982) 1.24
Muscle fiber disarray in common heart diseases. Am J Cardiol (1977) 1.19
Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: relation between the two and significance. Am Heart J (1981) 1.13
Myocardial disorganisation in hypertrophic cardiomyopathy. Another point of view. Br Heart J (1983) 1.06
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J (1985) 5.83
The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med (2006) 5.51
Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med (1984) 5.02
Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet (1989) 4.96
Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia (2012) 4.82
A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) (1993) 4.25
Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol (1997) 3.64
Biochemistry and pathology of radical-mediated protein oxidation. Biochem J (1997) 3.14
Dietary polyunsaturated fatty acids and composition of human aortic plaques. Lancet (1994) 2.69
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A (1991) 2.53
The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia (2007) 2.51
Community study of the causes of "natural" sudden death. BMJ (1988) 2.44
Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat (2002) 2.33
The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material. Br Heart J (1978) 2.28
Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet (2003) 2.25
Retrospective review of care and outcomes in young adults with type 1 diabetes. BMJ (2003) 2.22
Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials. BMJ (2010) 2.19
Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia (2013) 2.19
Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis (1991) 2.10
The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med (2010) 2.09
Unexplained death in fit young people. BMJ (1992) 2.03
Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol (2001) 1.91
Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br Heart J (1976) 1.83
Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids (2003) 1.79
Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation (1986) 1.78
Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet (1991) 1.76
Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol (2001) 1.74
Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res (1987) 1.74
The demonstration of cardiac pathology using perfusion-fixation. Histopathology (1985) 1.72
Generation and propagation of radical reactions on proteins. Biochim Biophys Acta (2001) 1.70
Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes. Diabetes Obes Metab (2008) 1.68
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart (2000) 1.66
Bed rest and postlumbar puncture headache. The effectiveness of 24 hours' recumbency in reducing the incidence of postlumbar puncture headache. Anaesthesia (1989) 1.64
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation (2001) 1.64
Anatomical basis of cross sectional echocardiography. Br Heart J (1983) 1.63
The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years? Diabet Med (2011) 1.61
Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart (1999) 1.59
Idiopathic giant cell myocarditis--a distinctive clinico-pathological entity. Br Heart J (1975) 1.59
Post-mortem investigation and quantification of coronary artery disease. Histopathology (1985) 1.51
Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J (1990) 1.49
Caries experience among children in fluoridated Townsville and unfluoridated Brisbane. Aust N Z J Public Health (1996) 1.48
The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. Int J Clin Pract (2011) 1.47
Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J (1998) 1.45
Associations between exposure to fluoridated drinking water and dental caries experience among children in two Australian states. J Public Health Dent (1995) 1.45
Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency. Diabetes Obes Metab (2008) 1.44
Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res (2001) 1.44
Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study. Int J Clin Pract (2010) 1.43
Reactive species and their accumulation on radical-damaged proteins. Trends Biochem Sci (1993) 1.42
Haematological effects of reinfused mediastinal blood after cardiac surgery. Med J Aust (1991) 1.42
The relation of coronary thrombosis to ischaemic myocardial necrosis. J Pathol (1979) 1.42
Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception. Diabet Med (2013) 1.41
Oxidative stress in a rat model of obesity-induced hypertension. Hypertension (2001) 1.41
Ventricular preexcitation. A proposed nomenclature for its substrates. Eur J Cardiol (1975) 1.39
Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation (1996) 1.39
Assessment of the use of disposable skin staplers in bowel anastomoses to reduce laparotomy time in penetrating ballistic injury to the abdomen. Ann R Coll Surg Engl (1992) 1.39
Self-monitoring of blood glucose versus self-monitoring of urine glucose in adults with newly diagnosed Type 2 diabetes receiving structured education: a cluster randomized controlled trial. Diabet Med (2014) 1.39
Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr Med Chem (2006) 1.38
Pre-excitation due to accessory sinoventricular connexions associated with coronary sinus aneurysms. A report of two cases. Br Heart J (1985) 1.38
Quantitative study of ageing changes in the human sinoatrial node and internodal tracts. Br Heart J (1972) 1.37
A new look at the neonatal electrocardiogram. Br Med J (1976) 1.36
Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia (2013) 1.36
Coxsackie B viruses and human heart disease. Curr Top Microbiol Immunol (1997) 1.32
Development of hypertension in a rat model of diet-induced obesity. Hypertension (2000) 1.31
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.31
A histological study of the conduction system in complete heart block. J Pathol Bacteriol (1967) 1.31
How can structured self-management patient education improve outcomes in people with type 2 diabetes? Diabetes Obes Metab (2009) 1.30
Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol (1991) 1.30
Left-ventricular endomyocardial biopsy. Lancet (1974) 1.25
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach. Diabetes Obes Metab (2008) 1.24
Smokers' preferences for assistance with cessation. Prev Med (1990) 1.24
The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries. Philos Trans R Soc Lond B Biol Sci (1981) 1.22
Sudden, unexpected cardiac or unexplained death in England: a national survey. QJM (2003) 1.21
The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus. Diabet Med (2010) 1.20
Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod (2001) 1.20
Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J (1980) 1.20
The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth (1992) 1.17
Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem J (1998) 1.17
Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod (2001) 1.17
O-linked protein glycosylation structure and function. Glycoconj J (1996) 1.16
Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol (1997) 1.16
The cytoplasmic Cu,Zn superoxide dismutase of saccharomyces cerevisiae is required for resistance to freeze-thaw stress. Generation of free radicals during freezing and thawing. J Biol Chem (1998) 1.15
The composition of coronary-artery plaques. N Engl J Med (1997) 1.15
Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab (2008) 1.15
Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity. Diabetologia (2010) 1.15
A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart (1999) 1.14
The human atrioventricular junctional area. A morphological study of the A-V node and bundle. Eur J Cardiol (1975) 1.13
Pathology of atrial fibrillation in man. Br Heart J (1972) 1.13
A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity. Obes Rev (2012) 1.12
Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia (2012) 1.11
Atrial myxoma: a tumour in search of its origins. Br Heart J (1992) 1.11
The assessment of cardiac hypertrophy at autopsy. Histopathology (1985) 1.10
The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev (2012) 1.10
Heart block and coronary artery disease. Br Med J (1967) 1.10
U-500 insulin: why, when and how to use in clinical practice. Diabetes Metab Res Rev (2007) 1.09
Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med (1996) 1.09
Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials. Free Radic Biol Med (1996) 1.08
Morphological characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J (1986) 1.07
Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study. Diabetologia (2011) 1.07